Alzheimer's Drugs Arrived Brain Scanners Didn't with Jannis Fischer
About this episode
Jannis Fischer discusses the challenges and innovations in Alzheimer's diagnostics with a focus on Positrigo's new brain PET scanner.
Alzheimer's treatments finally exist but patients are waiting months for the brain scans they need to access them. In this episode, Jannis Fischer, CEO and co-founder of Positrigo, explains how his team built an ultra-compact brain PET scanner that fits inside a neurologist's office and cuts diagnostic timelines from months to days. From losing an investor the day before signing to FDA clearance and triple-digit patient volumes within weeks of launch, this is a founder story with real clinical stakes. Key Topics Why new Alzheimer's drugs have created a brain PET bottleneck How Positrigo's NeuroLF scanner delivers diagnostic-quality imaging in a seated, 10–20 minute scan The "land and expand" go-to-market strategy across US neurology offices Navigating FDA clearance and CE mark on ~€15M in funding Transitioning from R&D organisation to customer-centric commercial operation Fundraising a $25–35M growth round to scale from proof of concept to exit-readiness Related Insights Roche, Eli Lilly and Biogen are running trials on preventive Alzheimer's intervention blood tests could pre-screen patients before symptoms appear The reimbursement landscape for brain PET is…
Topics covered
- Alzheimer's drugs
- brain PET scanner
- diagnostic imaging
- FDA clearance
- neurology practices
- fundraising
- point-of-care diagnostics
Keywords
- Alzheimer's
- brain scans
- diagnostic timelines
- NeuroLF scanner
- FDA clearance
- funding
- neurology
More episodes of The Crux of Medtech
- Kidney Monitoring Hasn’t Changed Since 1936 with Todd Dunn
- Robotic Prostatectomy Has Run Its Course with Dr. Arun Menawat
- The AI That Reads ECGs Better Than Your Cardiologist with Martin Herman
- Nobody Can See What's Happening in Surgery with Bruno Dheedene
- Cardiac Ablation Has A 50% Problem, Here's The Fix with Andreu Climent
- Why Medtech Is Still Decades Behind Fintech with Esther Reynal
Explore listener stats, chart rankings, contacts and more on the The Crux of Medtech podcast page.